Darnytsia (company)

Darnytsia (Ukrainian: Дарниця) is a Ukrainian pharmaceutical company.

Darnytsia
Darnytsia
Native name
Дарниця
TypePrivate
IndustryPharmaceutical industry
Predecessor
  • Kyiv branch of the Ukrainian Institute of Experimental Endocrinology
  • Darnitsa Chemical and Pharmaceutical Plant
  • Kyiv industrial chemical and pharmaceutical association Darnitsa
  • Collective enterprise Pharmaceutical firm Darnitsa
  • CJSC Pharmaceutical Firm Darnitsa
Headquarters
Kyiv
,
Ukraine
Key people
RevenueUS$100 million (2020)
Number of employees
1,100[1] (2020)
Websitewww.darnitsa.ua/en

History

In 1930, the Kyiv branch of the Ukrainian Institute of Experimental Endocrinology was established, which produced the first drugs in 1932. In particular, hematogen (liquid and tablets). In 1938, new production buildings were put into operation, and by 1940, the production capacity amounted to 4 million units of products, in monetary terms being about 5 million roubles.[2][3]

During the Second World War, Darnytsia was evacuated to the Urals. In 1950, the Kyiv enterprise was practically restored, and by 1952, the capacity was brought to 15.19 million units of production. In 1954, the branch of the institute was reorganized into the Darnytsia Chemical and Pharmaceutical Plant. At first, it specialized in the production of solutions for injection in ampoules. In the 1960s, a glass-blowing manufacturing facility with a capacity of 300 million ampoules was put into operation.[2]

In 1976, the Kyiv industrial chemical and pharmaceutical association Darnytsia was established. The products of the combined enterprise were exported to 37 countries of the world.[4] In 1985, the Monastyryshchenskyi Chemical and Pharmaceutical Plant was added to this association.[2]

In 1993, Darnytsia was transformed into a collective enterprise.[5] In 1994, the company became a closed joint stock company (CJSC), and since 2012, it has been a private joint stock company (PrJSC).[6]

In the 1990s, Darnytsia began to re-equip production in accordance with the requirements of the GMP (Good Manufacturing Practice) standard.[7] By 2010, according to a study by O. Posylkina and M. Sidorenko, the company was ahead of other Ukrainian enterprises, having certified 5 sites where 112 different drugs were produced.[8]

During the same period, the main production was modernized. In 1997, the reconstruction of the area for aseptic preparation and bottling of medicines was completed. In 2000, the system for obtaining drinking-quality water was reconstructed, in 2002, a new plant of sterile cephalosporin antibiotics was launched, in 2012, the ampoule production was re-equipped.[9]

In the early 2000s, Darnytsia and four other largest enterprises in Ukraine occupied 21% of the Ukrainian market in monetary terms and 32% in physical terms. Those manufacturers provided more than half of all types of medicines produced by the entire Ukrainian pharmaceutical industry (65 factories, 27 pharmaceutical plants, 119 small enterprises and separate workshops).[10]

In 2008, with the help of the German company Schäfer, a logistics complex with a total area of 15 thousand square meters was launched, where there is a robotic high-rise warehouse (32 meters) for 10 thousand pallet places.[11][12]

According to research by Mykola Grebnev and Inna Vinnikova, by 2009 the company had a production area of more than 30 thousand square meters. The production capacity made it possible to produce over 500 million ampoules, 4 billion tablets, 10 million tubes of soft dosage forms, 30 million vials of sterile antibiotics and 35 million drop vials. According to various estimates, the company's share in the Ukrainian pharmaceutical market was about 7%.[13]

In 2014, the company's net income amounted to ₴1.2 billion. This was the third place among the Ukrainian pharmaceutical manufacturers. In 2015, Darnytsia also ranked third in terms of sales in pharmacies (among 620 Ukrainian and 1,561 foreign participants).[14]

In 2016, Darnytsia was included into the Top 20 most innovative companies in Ukraine by Forbes Ukraine.[15][16] The company has implemented an ERP system that allows it to control logistics, plan sales and focus a specific production for a specific demand.[17]

In 2019, the company was rebranded.[18]

Social responsibility and charity

According to Natalia Tkachenko, in 2012, Darnytsia was among the top three companies in terms of disclosure of information on corporate social responsibility (among the 20 largest pharmaceutical manufacturers in Ukraine).[19][20]

Olga Rogulya gives a number of figures for 2019. Among the philanthropic projects, university scholarships were funded for ₴3.4 million, a study of public issues and educational activities of The Aspen Institute Kyiv was funded for ₴1 million, as well as scholarships for participants in the Petro Jacyk International Competition for Experts in the Ukrainian Language.[21]

Assistance to charitable foundations amounted to ₴23.3 million. Social programs and projects were funded, in particular, "З турботою про співвітчизника" ("Taking care of a compatriot"), #GivingTuesday, "Твій безмежний світ" ("Your boundless world").[22]

References
  1. "50 найкращих роботодавців" [50 best employers]. Forbes Ukraine (in Ukrainian). 4 January 2021. Archived from the original on 28 April 2021. Retrieved 12 August 2021.
  2. Шквир О.М. (2007). "Дарниця Фармацевтична фірма" [Pharmaceutical company Darnitsa]. Encyclopedia of Modern Ukraine (in Ukrainian). Archived from the original on 13 May 2021. Retrieved 12 August 2021.
  3. Ілляшенко, І.О. (April 2016). "Історія розвитку та сучасний стан медичної промисловості Києва" [History of development and current state of the medical industry in Kyiv] (PDF). Глобальні та національні проблеми економіки (in Ukrainian) (10). Archived from the original (PDF) on 2 June 2021. Retrieved 12 August 2021.
  4. Карпенко, І.В. (1980). Бажан, М.П. (ed.). "Київське виробниче хіміко-фармацевтичне об'єднання "Дарниця"" [Kyiv Production Chemical and Pharmaceutical Association "Darnytsia"] (PDF). Ukrainian Soviet Encyclopedia (in Ukrainian). 5: 138. Archived from the original (PDF) on 15 May 2021. Retrieved 12 August 2021.
  5. Екатерина Гребеник (25 September 2015). "Семейный рецепт: что спасло фармкомпанию "Дарница"" [A family recipe: What saved the pharmaceutical company "Darnitsa"]. Forbes Ukraine (in Russian). Archived from the original on 4 October 2015. Retrieved 19 August 2021.
  6. ""Дарница" фармацевтическая фирма" ["Darnitsa" pharmaceutical company]. LB.ua (in Russian). 29 November 2016. Archived from the original on 29 March 2021. Retrieved 12 August 2021.
  7. Елена Жога (28 January 2021). "Дело Марцинчиков, или как родились киевские фармгиганты" [The Marcinchikovs case, or how the Kyiv pharma giants were born]. ThePharma.Media (in Russian). Archived from the original on 27 February 2021. Retrieved 12 August 2021.
  8. Посилкіна, О.В.; Сидоренко, М.І. (2010). "Актуальні аспекти управління якістю наукової діяльності у фармацевтичній галузі" [Actual aspects of quality management of scientific activity in the pharmaceutical field] (PDF). Вісник Національного університету "Львівська політехніка" (in Ukrainian). Lviv Polytechnic (684): 30. Archived from the original (PDF) on 2 June 2021. Retrieved 12 August 2021.
  9. "Фармацевтическая компания Дарница" [Pharmaceutical company Darnitsa]. Liga.net (in Russian). 30 July 2019. Archived from the original on 28 June 2021. Retrieved 12 August 2021.
  10. Мороз, Л.А.; Савченко, Ю.Т. (2002). "Маркетингові стратегії вітчизняних виробників на фармацевтичному ринку України" [Marketing strategies of domestic manufacturers in the pharmaceutical market of Ukraine] (PDF). Вісник Національного університету "Львівська політехніка" (in Ukrainian). Lviv Polytechnic (446). Retrieved 12 August 2021.
  11. "Строгий режим: как работает завод "Дарницы" во время карантина" [Strict regime: how the Darnitsa plant works during quarantine]. РБК-Україна (in Russian). 2020. Archived from the original on 2 June 2021. Retrieved 12 August 2021.
  12. Галина Галковская (30 September 2013). "Фармацевтическая компания "Дарница" — производитель европейского уровня" [Pharmaceutical company "Darnitsa" is a European-level manufacturer]. Apteka (Pharmacy) newspaper (in Russian). Archived from the original on 3 June 2021. Retrieved 12 August 2021.
  13. Гребньов, Микола; Віннікова, Інна (2009). "Управління якістю — як важливий чинник конкурентоспроможності на фармринку" [Quality management — as an important factor of competitiveness in the pharmaceutical market]. Маркетинг в Україні (in Ukrainian) (2): 60–63. ISSN 1606-3732. Archived from the original on 22 September 2020. Retrieved 12 August 2021.
  14. "ТОП-100 медицинских компаний Украины" [TOP-100 medical companies in Ukraine]. Рейтинги крупнейших (in Russian). Kyiv: DELO (2): 66–69. 2 April 2016. Archived from the original on 18 March 2017. Retrieved 12 August 2021.
  15. Иван Скавронский (26 July 2016). "Как национальные производители отвоевывают украинский фармрынок" [How national manufacturers are conquering the Ukrainian pharmaceutical market]. DELO (in Russian). Archived from the original on 2 June 2021. Retrieved 12 August 2021.
  16. Швиданенко, Г.О.; Бойченко, К.С. (2017). "Інноваційна модель розвитку бізнесу в Україні" [Innovative model of business development in Ukraine] (PDF). Вісник Хмельницького національного університету (in Ukrainian). Khmelnytskyi: Khmelnytskyi National University (4): 195. Archived from the original (PDF) on 2 June 2021. Retrieved 12 August 2021.
  17. Роман Корнилюк, Павел Харламов, Евгений Шишацкий (25 May 2016). "Спасти будущее: первый рейтинг инновационных компаний Украины" [To save the future: the first rating of innovative companies in Ukraine]. Forbes Ukraine (in Russian). Archived from the original on 26 November 2016.{{cite web}}: CS1 maint: multiple names: authors list (link)
  18. "ТОП-25 украинских брендов" [TOP-25 Ukrainian brands]. Delovaya Stolitsa (in Russian). 24 February 2020. Archived from the original on 4 June 2021. Retrieved 12 August 2021.
  19. Ткаченко, Н.О.; Червоненко, Н.М.; Книш, Є.Г. (2013). "Сучасний стан і характеристика соціальної відповіднальності підприємницької діяльності" [Current state and characteristics of social responsibility of entrepreneurial activity] (PDF). Запорожский медицинский журнал (in Ukrainian). Zaporizhzhia: Zaporizhzhia State Medical University. 2 (77): 80. ISSN 2519-8807. Archived from the original (PDF) on 2 June 2021. Retrieved 12 August 2021.
  20. Ткаченко, Н.О. (2020). "Дослідження стану та напрямів соціальної активності суб'єктів фармацевтичного підприємництва" [Research of the state and directions of social activity of the subjects of pharmaceutical business] (PDF). Management, Economy and Quality Assurance in Pharmacy (in Ukrainian). Zaporizhzhia: Zaporizhzhia State Medical University. 3 (63): 51. ISSN 2519-8807. Archived from the original (PDF) on 2 June 2021. Retrieved 12 August 2021.
  21. Рогуля О.Ю. (2020). Соціальні аспекти конкурентоспроможності фармацевтичних підприємств (PDF) (The 8th International scientific and practical conference "Dynamics of the development of world science" (April 15-17, 2020) ed.). Vancouver: Perfect Publishing. pp. 744–746. ISBN 978-1-4879-3791-1. Archived from the original (PDF) on 2 June 2021.
  22. Рогуля, О.Ю. (2020). "Соціальні аспекти конкурентоспроможності фармацевтичних підприємств" [Social aspects of the competitiveness of pharmaceutical enterprises] (PDF). The 8th International Scientific and Practical Conference "Dynamics of the Development of World Science" (April 15–17, 2020) (in Ukrainian). Vancouver: Perfect Publishing: 744–746. ISBN 978-1-4879-3791-1. Archived from the original (PDF) on 2 June 2021. Retrieved 12 August 2021.
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.